Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.330
-0.120 (-2.70%)
At close: Jul 24, 2026, 4:00 PM EDT
4.340
+0.010 (0.23%)
Pre-market: Jul 27, 2026, 5:44 AM EDT
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Zentalis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.67. The average 1-year stock price forecast is 54.04% higher than the current stock price, while the lowest is $4.00 (-7.62%) and the highest is $10 (+130.95%).
Price Target: $6.67 (+54.04%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zentalis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $11 | Buy | Initiates | $11 | +154.04% | Jul 23, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Initiates $8 | Buy | Initiates | $8 | +84.76% | Jul 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +107.85% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +130.95% | May 26, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Hold Maintains $4 | Hold | Maintains | $4 | -7.62% | May 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
19.28M
EPS This Year
-1.67
from -1.80
EPS Next Year
-1.53
from -1.67
EPS and Forward PE are based on non-GAAP adjusted numbers.